Marksans Pharma gets EIR from USFDA for New York unit; stock up 5%

The company received EIR from the USFDA in respect of inspection of company's manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, USA.

Feb 11, 2020 12:02 IST India Infoline News Service

Marksans Pharma
Shares of Marksans Pharma zoomed 5% on the BSE in the afternoon session. The company received EIR from the USFDA in respect of inspection of company's manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, USA.

“We are pleased to announce receipt of Establishment Inspection Report (EIR) from the USFDA in respect of inspection of Company's manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, the USA carried out from December 5-18, 2019,” Marksans Pharma said in the filing.

Marksans Pharma Ltd is currently trading at Rs23.10, up by Rs1 or 4.52% from its previous closing of Rs22.10 on the BSE.

The scrip opened at Rs22.35 and has touched a high and low of Rs23.35 and Rs21.90 respectively.

Related Story